CHK2 inhibition provides a strategy to suppress hematological toxicity from PARP inhibitors
Zhen Xu(The Royal Melbourne Hospital), Ian J. Majewski(The University of Melbourne)
Cited by 0
Related Papers
Colorectal cancer intrinsic subtypes predict chemotherapy benefit, deficient mismatch repair and epithelial‐to‐mesenchymal transition
|International Journal of Cancer|2013|350
ChIP-seq analysis reveals distinct H3K27me3 profiles that correlate with transcriptional activity
|Nucleic Acids Research|2011|318
Uridine–cytidine kinase 2 potentiates the mutagenic influence of the antiviral β-d-N4-hydroxycytidine
|Nucleic Acids Research|2023|16